bioRxiv Science⌕ Search

bioRxiv · 10.64898/2026.10.19.760022

Variable sparsity non-negative matrix and tensor factorization algorithms and their applications in cancer genomics

Abstract

The field of oncology has experienced significant advancements in novel therapies and molecular diagnostics to personalize initial cancer treatments. However, cancer's propensity for evolution and resistance to therapies remains a formidable challenge due to its dynamic nature. Cancer's complex and adaptive behavior surpasses the capabilities of simple models, complicating our comprehension at every level, from basic sciences to clinical practices, highlighting the urgent need for innovative approaches to improve the modeling and classification of cancer. In this context, matrix factorization algorithms have been used to generate transcriptional signatures that summarize the most salient patterns of behaviors in cancer datasets. For example, the standard non-negative matrix factorization algorithm (NMF) generates a dimensionality-reduced representation that encodes a significant amount of data relationships as a mixture of positive components and provides a working summary of the input data. The resulting NMF factor matrices, W and H, display some degree of sparseness; however, this sparseness is often a byproduct rather than an explicit objective of the NMF algorithm, and the user has limited control over the degree of sparseness of the representation and the corresponding balance between local versus global structures in the NMF results. Some sparse versions of NMF have been introduced but still do not allow a fine-grained control on the sparsity constraints. We present here a novel variable-sparsity Non-negative Matrix Factorization algorithm (vsNMF), where instead of imposing sparsity as a regularization constraint on the NMF objective function, sparsity is explicitly enforced by a projective step performed for each column of W and row of H after a standard NMF update. In this way, the algorithm takes as input the input matrix, plus two one-dimensional vectors, that specify the sparsity functions that will be imposed on the NMF solution. The more explicit control of sparsity, and the corresponding balance between local vs. global structure, at the level of individual components, allows the generation of NMF solutions that can be tuned to operate anywhere between a generative, parts-based encoding of overlapping features, and a partitional, soft-clustering model. This allows greater flexibility to represent biological subtypes, patterns of pathway activation or deregulation, and higher biological interpretability. These learned low-dimensionality representations can also be used to integrate and merge datasets, or to define groups of similar cancer samples representing putative cellular or tumor states. Adjustable/tunable NMF representations of biological data can greatly help advance our fundamental understanding of cancer biology, provide more interpretable computational models of cancer, and better functional cancer taxonomies and precision oncology paradigms. We apply the same approach to tensors and introduce a variable-sparsity Non-Negative Tensor Factorization algorithm (vsNTF) that can take an input tensor and sparsity functions for each of the tensor dimensions.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Pham, T., Zhong, J., Hwang, J., Agarwala, R., Zhang, K., Mali, P., Kim, W., Tamayo, P.. 2026-10-19. Variable sparsity non-negative matrix and tensor factorization algorithms and their applications in cancer genomics. https://doi.org/10.64898/2026.10.19.760022

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

EMBER: Contextualized gene representations enable compositional prediction across cellular perturbations

Predicting the effects of individual and combined perturbations is central to identifying context-specific vulnerabilities and designing targeted interventions. Yet learning gene representations that integrate functional relationships with cellular state and transfer across perturbation tasks remains challenging. Here, we present EMBER, a gene-centric foundation model that learns context-dependent functional representations of genes. EMBER combines interaction-guided contrastive learning with masked expression reconstruction during pretraining on a single-cell corpus curated for diversity and balanced sampling across cell types and experimental batches. EMBER decouples gene representation learning from task-specific prediction through a composable embedding framework: the pretrained encoder remains frozen, while lightweight probes combine contextualized gene embeddings to predict individual and combined perturbation effects. The same pretrained representations support single-gene perturbation-response prediction, digenic interaction prediction, and multi-target drug-response prediction. EMBER improves cross-context perturbation-response prediction and genetic-interaction ranking relative to evaluated baselines. EMBER also prioritized SCFD1, a mediator of autophagosome-lysosome fusion, as a candidate dependency during mTOR inhibition. Together, these results establish contextualized gene embeddings as reusable building blocks for modeling genetic and pharmacological perturbations, supporting the prioritization of genetic interactions and context-specific interventions for experimental testing.

bioinformatics↗

Small molecule structure elucidation from NMR spectra with generative and reasoning models

Elucidating the structures of unknown small molecules remains a major challenge in chemistry, pharmacology, and drug discovery. While nuclear magnetic resonance (NMR) spectroscopy is the gold standard for structure elucidation, interpreting spectra remains labor-intensive and requires expert knowledge to navigate the vast space of possible structures. Here, we present an AI system for rapid, automated de novo structure elucidation that combines a molecular generative model with a scientific reasoning agent. Its generative component, ChefNMR2, is an atomic flow-matching model that predicts small-molecule structures from molecular formulae and one-dimensional 1H and 13C NMR spectra. ChefNMR2-Agent augments our generative model with large language models (LLMs) to reason over and refine candidate structures. Across diverse benchmarks, ChefNMR2 substantially outperforms existing tools, offering calibrated confidence estimates and two to three orders of magnitude faster inference than frontier LLMs. We use ChefNMR2-Agent to elucidate the structures of four novel natural products, matching human-chemist accuracy in a fraction of the time. Our work demonstrates how specialized generative models and general-purpose reasoning agents can unite to solve challenging scientific inverse problems and accelerate NMR structure elucidation, thus opening new possibilities for AI-driven small-molecule discovery across diverse disciplines.

bioinformatics↗

Digital twins forecast individual immune trajectories

The human immune system differs markedly between individuals and changes in response to infection, vaccination and treatment. AI virtual cells are being built to simulate cellular responses to perturbation. Yet these models, like most immune-response predictors, describe each person by a single pre-challenge measurement and forecast change from patterns pooled across people. Digital twins, updated with every new observation of an individual, could forecast how that person's immune state changes. Here we present ImmuneTwins, which builds these twins from single-cell profiles by personalizing a shared virtual-cell model with each individual's observations. In two external populations, ImmuneTwins reduced immune-age error by 32% and 42% relative to the best existing method. During repeated influenza vaccination, its twins predicted the direction of immune-cell change 35% more accurately than the best published method, and their error fell by 27% as observations accumulated. The twins revealed that immune cells and plasma proteins recover about half their deviation from a persistent personal reference within 90 days, whereas response size varies between challenges. They further localized B-cell remodelling in exceptional longevity and anticipated patient-specific immune trajectories during myeloma treatment. These results establish virtual-cell digital twins for forecasting individual immune change and identifying each person's characteristic immune features.

bioinformatics↗